Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release May 14 2021

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-may-14-2021-11

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 14, 2021, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases